Vascular endothelial growth factor gene polymorphisms and ovarian cancer survival

Gynecologic Oncology

Volumn 119, Issue 3, 2010, Pages 479-483

  Lose, Felicity ^a   Nagle, Christina M ^a   O'Mara, Tracy ^a,b   Batra, Jyotsna ^b   Bolton, Kelly L ^c,d   Song, Honglin ^c   Ramus, Susan J ^e   Gentry Maharaj, Aleksandra ^e   Menon, Usha ^e   Gayther, Simon A ^e   Pharoah, Paul D P ^c   Kedda, Mary Anne ^b   Spurdle, Amanda B ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Ovarian cancer; Polymorphisms; Survival; Vascular Endothelial Growth Factor

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; AUSTRALIA; CANCER INCIDENCE; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; DISEASE ASSOCIATION; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78149362120     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.08.014     Document Type: Article

References (38)

1. G.C. Kumaran, G.C. Jayson, and A.R. Clamp Antiangiogenic drugs in ovarian cancer Br J Cancer 100 2009 1 7
2. P.G. Artini, M. Ruggiero, P. Monteleone, A. Carpi, F. Cristello, and V. Cela Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors Biomed Pharmacother 62 2008 373 377
3. L. Li, L. Wang, W. Zhang, B. Tang, J. Zhang, and H. Song Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer Anticancer Res 24 2004 1973 1979
4. K.H. Lu, A.P. Patterson, L. Wang, R.T. Marquez, E.N. Atkinson, and K.A. Baggerly Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis Clin Cancer Res 10 2004 3291 3300
5. S.K. Kassim, E.M. El-Salahy, S.T. Fayed, S.A. Helal, T. Helal, D. Azzam Eel, and A. Khalifa Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients Clin Biochem 37 2004 363 369
6. C. Rudlowski, A.K. Pickart, C. Fuhljahn, T. Friepoertner, B. Schlehe, and S. Biesterfeld Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up Int J Gynecol Cancer 16 Suppl 1 2006 183 189
7. C. Tempfer, A. Obermair, L. Hefler, G. Haeusler, G. Gitsch, and C. Kainz Vascular endothelial growth factor serum concentrations in ovarian cancer Obstet Gynecol 92 1998 360 363
8. L.A. Hefler, R. Zeillinger, C. Grimm, A.K. Sood, W.F. Cheng, and A. Gadducci Preoperative serum vascular endothelial growth factor as a prognostic parameter in ovarian cancer Gynecol Oncol 103 2006 512 517
9. M.J. Goodheart, J.M. Ritchie, S.L. Rose, J.P. Fruehauf, B.R. De Young, and R.E. Buller The relationship of molecular markers of p53 function and angiogenesis to prognosis of stage I epithelial ovarian cancer Clin Cancer Res 11 2005 3733 3742
10. A. Alvarez Secord, R. Sayer, S.A. Snyder, G. Broadwater, G.C. Rodriguez, and A. Berchuck The relationship between serum vascular endothelial growth factor, persistent disease, and survival at second-look laparotomy in ovarian cancer Gynecol Oncol 94 2004 74 79
11. M. Garcia-Closas, N. Malats, F.X. Real, M. Yeager, R. Welch, and D. Silverman Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk PLoS Genet 3 2007 e29
12. M. Shahbazi, A.A. Fryer, V. Pravica, I.J. Brogan, H.M. Ramsay, and I.V. Hutchinson Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection J Am Soc Nephrol 13 2002 260 264
13. Steffensen KD, Waldstrom M, Brandslund I, Jakobsen A. The relationship of VEGF polymorphisms with serum VEGF levels and progression-free survival in patients with epithelial ovarian cancer. Gynecol Oncol.
14. M. Mohammadi, W. Ollier, and I.V. Hutchinson A functional association study of VEGF gene promoter polymorphisms with VEGF expression by stimulated PBM cells Hum Immunol 64 2003 S125
15. D. Lambrechts, E. Storkebaum, M. Morimoto, J. Del-Favero, F. Desmet, and S.L. Marklund VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death Nat Genet 34 2003 383 394
16. D. Petrovic, R. Verhovec, P.M. Globocnik, J. Osredkar, and B. Peterlin Association of vascular endothelial growth factor gene polymorphism with myocardial infarction in patients with type 2 diabetes Cardiology 107 2007 291 295
17. T. Awata, K. Inoue, S. Kurihara, T. Ohkubo, M. Watanabe, and K. Inukai A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes Diabetes 51 2002 1635 1639
18. A. Stevens, J. Soden, P.E. Brenchley, S. Ralph, and D.W. Ray Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter Cancer Res 63 2003 812 816
19. Y. Rosenbaum-Dekel, A. Fuchs, E. Yakirevich, A. Azriel, S. Mazareb, and M.B. Resnick Nuclear localization of long-VEGF is associated with hypoxia and tumor angiogenesis Biochem Biophys Res Commun 332 2005 271 278
20. U. Langsenlehner, W. Renner, B. Yazdani-Biuki, T. Eder, T.C. Wascher, and B. Paulweber Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk Breast Cancer Res Treat 97 2006 67 72
21. S.P. Balasubramanian, A. Cox, S.S. Cross, S.E. Higham, N.J. Brown, and M.W. Reed Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity Int J Cancer 121 2007 1009 1016
22. R. Cosin, J. Gilabert-Estelles, L.A. Ramon, F. Espana, J. Gilabert, and A. Romeu Vascular endothelial growth factor polymorphisms (-460C/T, + 405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression Fertil Steril 2008
23. T. Langsenlehner, U. Langsenlehner, W. Renner, P. Krippl, R. Mayer, and T.C. Wascher Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer Eur J Cancer 44 2008 1572 1576
24. B.P. Schneider, M. Radovich, G.W. Sledge, J.D. Robarge, L. Li, and A.M. Storniolo Association of polymorphisms of angiogenesis genes with breast cancer Breast Cancer Res Treat 111 2008 157 163
25. E.J. Jacobs, H.S. Feigelson, E.B. Bain, K.A. Brady, C. Rodriguez, and V.L. Stevens Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort Breast Cancer Res 8 2006 R22
26. E.J. Jacobs, A.W. Hsing, E.B. Bain, V.L. Stevens, Y. Wang, and J. Chen Polymorphisms in angiogenesis-related genes and prostate cancer Cancer Epidemiol Biomark Prev 17 2008 972 977
27. K. Dassoulas, M. Gazouli, S. Rizos, G. Theodoropoulos, Z. Christoni, and N. Nikiteas Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival Mol Carcinog 2008
28. A.M. Schultheis, G. Lurje, K.E. Rhodes, W. Zhang, D. Yang, and A.A. Garcia Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab Clin Cancer Res 14 2008 7554 7563
29. L.A. Hefler, A. Mustea, D. Konsgen, N. Concin, B. Tanner, and R. Strick Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer Clin Cancer Res 13 2007 898 901
30. H. Song, S.J. Ramus, J. Tyrer, K.L. Bolton, A. Gentry-Maharaj, and E. Wozniak A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2 Nat Genet 41 2009 996 1000
31. M.T. Goodman, C.N. Correa, K.H. Tung, S.D. Roffers, X. Cheng Wu, and J.L. Young Jr. Stage at diagnosis of ovarian cancer in the United States, 1992-1997 Cancer 97 2003 2648 2659
32. P. Scheet, and M. Stephens A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase Am J Hum Genet 78 2006 629 644
33. J. Marchini, B. Howie, S. Myers, G. McVean, and P. Donnelly A new multipoint method for genome-wide association studies by imputation of genotypes Nat Genet 39 2007 906 913
34. M. Stephens, and P. Donnelly A comparison of bayesian methods for haplotype reconstruction from population genotype data Am J Hum Genet 73 2003 1162 1169
35. L. Quaye, S.A. Gayther, S.J. Ramus, R.A. Di Cioccio, V. McGuire, and E. Hogdall The effects of common genetic variants in oncogenes on ovarian cancer survival Clin Cancer Res 14 2008 5833 5839
36. S. Sfar, E. Hassen, H. Saad, F. Mosbah, and L. Chouchane Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome Cytokine 35 2006 21 28
37. Q. Jin, K. Hemminki, K. Enquist, P. Lenner, E. Grzybowska, and R. Klaes Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis Clin Cancer Res 11 2005 3647 3653
38. R.S. Heist, R. Zhai, G. Liu, W. Zhou, X. Lin, and L. Su VEGF polymorphisms and survival in early-stage non-small-cell lung cancer J Clin Oncol 26 2008 856 862